Partnering

INSIGHTS ON CLINICAL TRIAL PARTNERING

AI-Powered Strategy Is Redefining Patient Recruitment Performance
This AI-powered platform is helping CROs and sponsors tackle the unsolved challenge they've faced for decades: clinical trials that launch late, recruit slowly, and miss enrollment targets.
Ethical & Regulatory Considerations For Pediatric Gene Therapy
Understanding risk thresholds, consent requirements, and IRB expectations early can prevent redesign, reduce delays, and improve trial feasibility for vulnerable patient populations
De-Risking FIH: Integrated Strategies For Rapid Proof-Of-Concept
Proper planning for first-in-human studies is crucial to successful drug development, which requires innovative trial designs and sound CMC strategies to mitigate risk and expedite proof-of-concept.
Biorepository And Lab Services
Beyond basic storage, our comprehensive services deliver fully compliant, state-of-the-art environments where samples are meticulously cataloged, tracked, and maintained with precision.

Rescuing A Global Full-Service Phase III Trial For A Late-Stage Oncology Biotech
10/2/2025

This case underscores the expertise employed in a comprehensive strategy and set of services that were used to salvage a Phase III clinical trial for ovarian cancer and ensure its timely completion.
Elevating The Site Voice
3/27/2025

A decentralized trial can be daunting for sites, but Medidata offers solutions to help site staff, sponsors, and patients move smoothly through the clinical trial process.
Unlocking The Benefits Of Site Payment Platforms: Part 1
12/5/2025

By standardizing workflows, ensuring audit-ready documentation, and providing actionable real-time insights, these platforms mitigate operational risks while supporting better financial oversight.
New Purpose-Built Facility For Large-Scale Sterile Fill/Finish Operations
7/17/2025

Expanding capacity for late-phase clinical and large-scale commercial small molecule and biologic drugs, a new facility boosts sterile fill/finish capabilities.
Reducing The Travel Burden For Patients - The Benefits Of Mobile Vision Clinics
3/11/2025

Travel to trial sites can be a major hurdle for patients considering participation, but mobile vision clinics are providing a solution to improve accessibility, capacity, and patient enrollment.

Safe-To-Site Initiative

By combining proactive safety measures, personalized support, and reliable logistics, the Safe-to-Site Initiative enhances the clinical trial experience by removing the challenges of participation.
Creating Powerful Partnerships

Deepen your impact in global healthcare through thought leadership, education, conferences, and partnerships that elevate visibility, strengthen expertise, and connect you with key HEOR stakeholders.
Diversity In STEM Scholarships In APAC, North America

With a strong focus on the Life Sciences industry, this program provides financial assistance, hands-on industry experience, and international visibility — helping create a more diverse and inclusive future for the life sciences sector.
Your Top Partner For Ophthalmic Drug Development

As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
Introducing One Home for Sites™

One Home for Sites is a vendor-agnostic, sponsor-agnostic, aggregation platform that provides single sign-on and more. Become part of the only industry-wide solution to site tech overload.